The Guardian: Better funding call for vital drug approval program
In her Global Health Blog for The Guardian, Sarah Boseley discusses a recently published article examining “[t]he prequalification of medicines program (PQP) of the WHO, launched in 2001, [which] was set up to assess the quality of the generic medicines for HIV and other diseases made by companies in India, China and elsewhere. … But, say four respected experts in the Journal of Public Health Policy, the program is endangered by its insecure funding…” (1/15).